Thanks w27 I had read your earlier post, but grateful for more explanation about RAMPs.
Not a share traded today! I think this reflects that we're in an information vacuum at the moment.
re this trial: the management of IVX already know from CBIO days it reduces IL6 (interleukin6) levels. These trial subjects have to go for lots of tests however, in addition to the dosings, and it all has to be done carefully. I'm assuming the shareprice has factored in that its a slam dunk... or maybe not (!). I guess investors have been burnt before.
Anyway, i look forward to analysing future news with you guys.
Factoid of the day --------------------
Where is this trial occuring?
Here: http://www.altoonaresearch.com
Altoona specialise in immunology trials. Its all very impressive and comforting for an investor that they are using Altoona.
IVX Price at posting:
9.4¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)